Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 225 - 232 of 11617 results
Checklist for Foreign Companies Expanding into the US
August 26, 2024| Advisory| Viewpoint
2024 Pre-Election Analysis: Health Care Issues
August 26, 2024| Advisory| Viewpoint
Justice Department Sues Software Maker RealPage for Enabling Rent Collusion
August 26, 2024| Alert| Viewpoint
California’s Health Care Transactions Review Law: Regulatory Revisions Effective Immediately
August 26, 2024| Blog| Viewpoint
The FTC’s Ban on Noncompetes Is No More. What Do Employers Do Now?
August 23, 2024| News
FTC Cracks Down on AI-Generated Fake Reviews – AI: The Washington Report
August 22, 2024| Article| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.